Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2011 | 03-2010 | 03-2009 | 03-2008 | 03-2007 | |
| Sales | 17,101,020 | 15,763,060 | 0 | 13,748,020 | 11,060,730 |
| Cost of Goods | 3,826,280 | 3,065,190 | N/A | 2,786,310 | 2,370,010 |
| Gross Profit | 13,274,730 | 12,697,870 | 12,742,780 | 10,961,710 | 8,690,720 |
| Operating Expenses | 8,852,310 | 8,179,650 | 4,622,910 | 6,730,790 | 4,805,130 |
| Operating Income | 4,422,709 | 4,518,409 | -4,622,910 | 4,231,229 | 3,885,601 |
| Interest Expense | 16,080 | 15,360 | 0 | 3,330 | 2,090 |
| Other Income | 70,141 | -31,769 | 0 | 1,540,521 | 1,416,309 |
| Pre-tax Income | 4,476,770 | 4,471,280 | -4,622,910 | 5,768,420 | 5,299,820 |
| Income Tax | 1,461,740 | 1,243,740 | N/A | 2,187,660 | 2,422,400 |
| Net Income Continuous | 2,934,118 | 3,209,680 | 2,343,850 | 3,120,886 | 2,874,491 |
| Net Income | $2,986,360 | $3,201,540 | $2,343,850 | $3,554,540 | $2,845,800 |
| EPS Basic Total Ops | 1.84 | 2.03 | 1.45 | 1.84 | 1.65 |
| EPS Basic Continuous Ops | 1.86 | 2.03 | 1.45 | 1.84 | 1.65 |
| EPS Diluted Total Ops | 1.84 | 2.03 | 1.45 | 1.84 | 1.65 |
| EPS Diluted Continuous Ops | 1.86 | 2.03 | 1.45 | 1.84 | 1.65 |
| EBITDA(a) | $15,748,510 | $5,753,079 | $-3,418,010 | $4,548,129 | $4,129,831 |